negatives of tirzepatide downsides what are some side effects The promise of tirzepatide: A narrative review of metabolic benefits Tirzepatide and Cardiovascular Outcomes: A – Mounjaro Injection - Uses, Side

Pharmacologic comparisons: In head-to-head and network trials (SURPASS versus comparators and SURMOUNT for obesity), tirzepatide produced larger mean reductions in HbA1c and body weight than many older agents and often greater weight loss than single-target GLP-1 drugsthis dual agonism is the hypothesized reason

And those individuals with pre-diabetes reduced their risk of developing diabetes over 2.8 years by 58% compared to the control group

Weeks three through six represent the window when measurable weight loss typically becomes visible

Treating the scale as one signal among many keeps it informative rather than overwhelming